切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2022, Vol. 15 ›› Issue (02) : 243 -245. doi: 10.3877/cma.j.issn.1674-6902.2022.02.027

短篇论著

智能化管理对COPD恢复期患者的影响
韩君1, 徐兴祥2,()   
  1. 1. 232000 淮南,安徽理工大学第一附属医院呼吸与危重症医学科
    2. 225002 扬州,苏北人民医院呼吸与危重症医学科
  • 收稿日期:2021-06-02 出版日期:2022-04-25
  • 通信作者: 徐兴祥

Influence of intelligent management on COPD convalescent patients

Jun Han1, Xingxiang Xu2()   

  • Received:2021-06-02 Published:2022-04-25
  • Corresponding author: Xingxiang Xu
引用本文:

韩君, 徐兴祥. 智能化管理对COPD恢复期患者的影响[J]. 中华肺部疾病杂志(电子版), 2022, 15(02): 243-245.

Jun Han, Xingxiang Xu. Influence of intelligent management on COPD convalescent patients[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2022, 15(02): 243-245.

表1 两组患者管理前后肺功能比较
表2 两组患者管理前后mMRC分级比较
表3 两组患者管理前后CAT评分比较
1
Gadoury MA, Schwartzman K, Rouleau M, et al. Self-management reduces both short- and long-term hospitalisation in COPD[J]. Eur Respir J, 2005, 26(5): 853-857.
2
Bourebau J, Julen M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention[J]. Arch Int Med, 2003, 163(5): 585-591.
3
Donaldson GC, Seemungal TAR, Patel IS, et al. Longitudinal changes in the nature, severity and frequency of COPD exacerbations[J]. Eur Respir J, 2003, 22(6): 931-936.
4
Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease(revised 2017) [EB/OL].2017.

URL    
5
任成山,王关嵩,钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
6
Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease[J]. Eur Respir, 2006, 27: 188.
7
Garcia-Aymerich Judith, Pons Ignasi Serra, Mannino David M, et al. Lung function impairment, COPD hospitalisations and subsequent mortality[J]. Thorax, 2011, 66(7): 585-590.
8
Weatherall M, Marsh S, Shirtcliffe P, et al. Quality of life measured by the st george′s respiratory questionnaire and spirometry[J]. Eur Respir J, 2009, 33(5): 1025-1030.
9
Toy Edmond L, Beaulieu Nicolas U, McHale Joshua M, et al. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs[J]. Respir Med, 2011, 105(3): 435-441.
10
Ramsey SD. Suboptimal medical therapy in COPD: exploring the causes and consequences[J]. Chest, 2000, 117(2 Suppl): 33S-37S.
11
Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting[EB/OL]. Clin Hypertens (Greenwich), 2008, 10: 348-354.
12
Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: Final response[EB/OL]. J Clin Epidemiol, 2011, 64: 262-263.
13
Rohr R. Rehospitalizations among patients in the Medicare fee-for-service program[J]. N Engl J Med, 2009, 361(3): 311-312.
14
Liu Shih-Feng, Lin Kuan-Chun, Chin Chien-Hung, et al. Factors influencing short-term re-admission and one-year mortality in patients with chronic obstructive pulmonary disease[J]. Respirology, 2007, 12(4): 560-565.
15
Liu Shih-Feng, Lin Kuan-Chun, Chin Chien-Hung, et al. Factors influencing short-term re-admission and one-year mortality in patients with chronic obstructive pulmonary disease[J]. Respirology, 2007, 12(4): 560-565.
16
Han MeiLan K, Martinez Carlos H, Au David H, et al. Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective[J]. Lancet Respir Med, 2016, 4(6): 473-526.
17
Ford Earl S, ?Murphy Louise B, ?Khavjou Olga, et al. Total and state-specific medical and absenteeism costs of COPD among adults aged 18 years in the United States for 2010 and projections through 2020[J]. Chest, 2015, 147(1): 31-45.
18
Pozo-Rodriguez F, Lopez-Campos JL, Alvarez-Martinez CJ, et al. Clinical audit of COPD patients requiring hospital admission in Spain: AUDIPOC study[J]. PLoS One, 2012, 7(7): e42156.
19
Makris D, Moschandreas J, Damianaki A, et al. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers[J]. Respir Med, 2007, 101(6):1305-1312.
20
Friedman B, Jiang HJ, Elixhauser A. Costly hospital readmissions and complex chronic illness[J]. Inquiry, 2008, 45(4): 408-421.
21
Cai Bai-qiang, Cai Shao-xi, Chen Rong-chang, et al. Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People′s Republic of China[J]. Int J Chron Obstruct Pulmon Dis, 2014, 9: 381-395.
22
Ramsey Scott D, Richard Hobbs FD. Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease[J]. Proc Am Thorac Soc, 2006, 3(7): 635-640.
23
Jensen Morten H, Cichosz Simon L, Dinesen Birthe, et al. Moving prediction of exacerbation in chronic obstructive pulmonary disease for patients in telecare[J]. J Telemed Telecare, 2012, 18(2): 99-103.
24
Pedone Claudio, Chiurco Domenica, Scarlata Simone, et al. Efficacy of multiparametric telemonitoring on respiratory outcomes in elderly people with COPD: a randomized controlled trial[J]. BMC Health Serv Res, 2013, 13: 82.
25
Rehman Hasan, Kamal Ayeesha K, Morris Pamela B, et al. Mobile health (mHealth) technology for the Management of hypertension and hyperlipidemia: slow start but loads of potential[J]. Curr Atheroscler Rep, 2017, 19(3): 12.
26
Kang Hannah, Park Hyeoun-Ae. A mobile app for hypertension Management based on clinical practice guidelines: development and deployment[J]. JMIR Mhealth Uhealth, 2016, 4(1): e12.
27
Yang Fen, Wang Yuncui, Yang Chongming, et al. Mobile health applications in self-management of patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis of their efficacy[J]. BMC Pulm Med, 2018, 18(1): 147.
28
Dale J, Connor S, Tolley K. An evaluation of the west surrey telemedicine monitoring project[J]. J Telemed Telecare, 2003, 9(Suppl 1): S39-S41.
[1] 张璐, 卞士柱. 肺动脉高压患者药物治疗依从性及健康管理分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 107-109.
[2] 晏妮, 董俊康, 张明周, 贺斌峰, 刘禹, 魏征华, 高瞻, 王关嵩. 焦虑抑郁对慢性阻塞性肺疾病患者生活质量的影响及药物依从性中介作用[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 771-775.
阅读次数
全文


摘要